Pimodivir 600 mg

DRUG2 trials

Sponsors

Janssen Research & Development, LLC

Conditions

Influenza A

Phase 3

A Study to Evaluate the Efficacy and Safety of Pimodivir in Combination With the Standard-of-Care Treatment in Adolescent, Adult, and Elderly Hospitalized Participants With Influenza A Infection

TerminatedNCT03376321

Janssen Research & Development, LLCInfluenza A

Start: 2018-01-03End: 2020-04-30Updated: 2025-02-04

A Study to Evaluate the Efficacy and Safety of Pimodivir in Combination With the Standard-of-Care Treatment in Adolescent, Adult, and Elderly Non-Hospitalized Participants With Influenza A Infection Who Are at Risk of Developing Complications

TerminatedNCT03381196

Janssen Research & Development, LLCInfluenza A

Start: 2018-01-21End: 2020-08-24Updated: 2025-02-04

Related Papers

Efficacy and Safety of Pimodivir Combined With Standard of Care in Hospitalized and Nonhospitalized High-Risk Adolescents and Adults With Influenza A Infection

The Journal of Infectious Diseases2024-08-225 citations

A Phase 2 Study of Pimodivir (JNJ-63623872) in Combination With Oseltamivir in Elderly and Nonelderly Adults Hospitalized With Influenza A Infection: OPAL Study.

2022-08-0123 citations